Literature DB >> 18475095

Bronchiolitis obliterans in children.

Siby P Moonnumakal1, Leland L Fan.   

Abstract

PURPOSE OF REVIEW: In this review, we discuss recent advances in our understanding of the etiology, pathology and pathogenesis, clinical presentation, diagnosis, treatment, and outcome of bronchiolitis obliterans in the nontransplant, pediatric population. RECENT
FINDINGS: The diagnosis of bronchiolitis obliterans in children can be made with confidence based on clinical presentation, particularly with a history of adenovirus bronchiolitis or pneumonia, fixed obstructive lung disease on pulmonary function testing, and characteristic changes of mosaic perfusion, vascular attenuation, and central bronchiectasis on chest high-resolution computed tomography, thus avoiding the need for lung biopsy in most patients. Patients with postinfectious bronchiolitis obliterans generally have chronic, nonprogressive disease; in contrast, patients with bronchiolitis obliterans from Stevens-Johnson syndrome often have progressive disease that may require lung transplantation.
SUMMARY: Bronchiolitis obliterans is a rare form of chronic obstructive lung disease that follows a severe insult to the lower respiratory tract, resulting in fibrosis of the small airways. In the nontransplant pediatric population, adenovirus infection is the most common cause. Treatment is largely supportive and prognosis is mainly related to the underlying cause and to the severity of the initial insult.

Entities:  

Mesh:

Year:  2008        PMID: 18475095     DOI: 10.1097/MOP.0b013e3282ff62e9

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  31 in total

1.  Post-measles bronchiolitis obliterans in a 3-y-old girl.

Authors:  Mandeep Walia; Vishnu Goyal; Pankaj Jain
Journal:  Indian J Pediatr       Date:  2011-10-20       Impact factor: 1.967

2.  Bronchiolitis obliterans associated with Stevens-Johnson syndrome and response to azathioprine.

Authors:  Shivani Dogra; Arushi G Saini; Deepti Suri; Amit Rawat; K S Sodhi; Surjit Singh
Journal:  Indian J Pediatr       Date:  2013-09-07       Impact factor: 1.967

Review 3.  Managing wheeze in preschool children: How difficult can it be?

Authors:  Shaikh M Iqbal
Journal:  Sudan J Paediatr       Date:  2012

4.  Lung Clearance Index (LCI) in Patients with Bronchiolitis Obliterans: A Preliminary Report and Comparison to Cystic Fibrosis Patients.

Authors:  Michal Gur; Karin Yaacoby-Bianu; Anat Ilivitzki; Ronen Bar-Yoseph; Vered Nir; Fahed Hakim; Yazeed Toukan; Lea Bentur
Journal:  Lung       Date:  2016-08-31       Impact factor: 2.584

5.  Infants and Young Children with Children's Interstitial Lung Disease.

Authors:  Robin R Deterding
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

6.  Diagnostic Pathology of Diffuse Lung Disease in Children.

Authors:  Megan K Dishop
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

7.  Bilateral pulmonary nodules in an adult patient with bronchiolitis obliterans-organising pneumonia.

Authors:  Antonios Kopanakis; Christos Golias; George Pantentalakis; Michalis Patentalakis; Charalampos Mermigkis; Christos Mermigkis; Alexandros Charalabopoulos; Dimitrios Peschos; Anna Batistatou; Konstantinos Charalabopoulos
Journal:  BMJ Case Rep       Date:  2009-02-27

8.  Post-infectious bronchiolitis obliterans in children: CT features that predict responsiveness to pulse methylprednisolone.

Authors:  H M Yoon; J S Lee; J-Y Hwang; Y A Cho; H-K Yoon; J Yu; S-J Hong; C H Yoon
Journal:  Br J Radiol       Date:  2015-02-24       Impact factor: 3.039

9.  [Value of anti-neutrophil cytoplasmic antibody in assessing the severity of bronchiolitis obliterans in children].

Authors:  Xiao-Wen Chen; De-Hui Chen; Shang-Zhi Wu; Na Xie; Wen-Kuan Liu; Yu-Neng Lin; Ya-Wen Zhang; Qing-Si Zeng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

10.  Imaging of Childhood Interstitial Lung Disease.

Authors:  R Paul Guillerman
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.